A Mount Sinai retrospective analysis suggests GLP-1 receptor agonists may reduce cardiovascular risk, inflammation, and disease severity in hidradenitis suppurativa.
Imagine you're cruising down the highway, when suddenly you hear something that sounds like a gunshot. You haven't been hit, your engine hasn't exploded, and your tires are all still intact. Instead, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results